Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,761.00
Bid: 1,757.50
Ask: 1,758.00
Change: 27.50 (1.59%)
Spread: 0.50 (0.028%)
Open: 1,736.00
High: 1,767.00
Low: 1,736.00
Prev. Close: 1,733.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London open: Stocks fall on Chinese data, US growth

Thu, 21st Jun 2012 08:40

- Chinese PMI falls to seven-month low- Fed extends 'the twist', lowers GDP forecast- Miners provide a drag in LondonDisappointing economic data from China and a downward revision to US growth dented the Footsie in early trading on Thursday, with mining stocks bearing the brunt of the sell-off.The Chinese manufacturing sector purchasing managers' index for the month of June compiled by Markit fell from 48.4 to 48.1 in June, a seven-month low. Many observers believe that the Asian powerhouse will bottom-out in the current quarter. Commenting on the Flash China Manufacturing PMI, Hongbin Qu, chief economist, China & Co-Head of Asian Economic Research at HSBC said: "China's manufacturing sector continued to slow in June, though the pace of slowdown seems to be slowing. With external headwinds remaining strong, exports are likely to decelerate in the coming months. The sharp fall of prices and moderation of new orders suggest weak domestic demand, posing destocking pressures for Chinese manufacturers. All will likely weigh on the jobs market. As such, we expect more decisive policy stimulus to reverse the growth slowdown." In other news, the keenly-awaited policy decision in the US last night failed to boost markets as was hoped, after the Federal Reserve also downgraded its growth expectations for the world's largest economy. Fed Chairman Ben Bernanke said that the European crisis was "slowing US economic growth." While the Federal Open Market Committee decided to extend its 'Operation Twist' programme, which involving the sale of short-term debt in exchange for long-term securities with the intention of flattening the interest rate curve, the central bank said it expects US GDP to grow by 1.9-2.4% in 2012, down from earlier predictions of a 2.4-2.9% expansion. In Eurozone news, there were rumours that German Chancellor Angela Merkel has said that bond purchases by the European bail-out funds are a possibility.Company movements: Miners tank after China dataConcerns over the Chinese economy pressured sharp falls in the mining sector this morning as investors expressed worries about slowing demand. Vedanta, Kazakhmys, Xstrata, Glencore, Rio Tinto, BHP Billiton, Antofagasta, Anglo American and Polymetal dominated the fallers list.With investors fleeing from these 'riskier' assets, defensive sectors were in demand with pharmaceuticals group GlaxoSmithKline and AstraZeneca, and tobacco giant BATS on the rise.Water company Severn Trent rose after announcing the launch of a 10-year sterling bond with a coupon linked to the retail prices index. The bonds will pay interest semi-annually at a real rate of interest of 1.3% per annum adjusted to take account of changes in the level of the UK Retail Prices Index (RPI). The bonds, to be issued at £100 a throw, could, however, end up paying less than 1.3% per year if the UK experiences deflation.FTSE 250 construction equipment leasing firm Ashtead Group jumped early on after reporting record profits as tight cost control and strong demand in the US helped the firm beat analyst expectations. Bid talks which got the market excited on Wednesday about Invensys, the maker of rail signalling and industrial automation systems, have hit the buffers already causing shares to pull back. In response to press speculation about an approach from Emerson Electric for some of the company'sassets, news of which leaked out on Wednesday, Invensys said talks with Emerson are no longer taking place. FTSE 100 - RisersGlaxoSmithKline (GSK) 1,479.50p +1.06%Reckitt Benckiser Group (RB.) 3,400.00p +0.98%Unilever (ULVR) 2,077.00p +0.73%Associated British Foods (ABF) 1,242.00p +0.65%Aggreko (AGK) 2,112.00p +0.62%AstraZeneca (AZN) 2,783.00p +0.60%Pearson (PSON) 1,216.00p +0.50%British American Tobacco (BATS) 3,233.50p +0.42%Shire Plc (SHP) 1,952.00p +0.41%Compass Group (CPG) 655.00p +0.38%FTSE 100 - FallersVedanta Resources (VED) 934.00p -4.50%Kazakhmys (KAZ) 721.50p -4.50%Xstrata (XTA) 839.70p -3.49%Glencore International (GLEN) 321.70p -3.47%Rio Tinto (RIO) 2,998.00p -3.13%Weir Group (WEIR) 1,512.00p -2.95%Antofagasta (ANTO) 1,090.00p -2.85%Anglo American (AAL) 2,152.50p -2.82%BHP Billiton (BLT) 1,824.50p -2.72%Eurasian Natural Resources Corp. (ENRC) 425.90p -2.34%FTSE 250 - RisersAshtead Group (AHT) 267.80p +6.95%Stobart Group Ltd. (STOB) 121.70p +2.87%Interserve (IRV) 304.20p +1.47%Micro Focus International (MCRO) 458.40p +1.42%Rank Group (RNK) 122.40p +1.41%Barr (A.G.) (BAG) 435.00p +1.16%Bank of Georgia Holdings (BGEO) 1,011.00p +1.10%Rathbone Brothers (RAT) 1,213.00p +1.08%Aberforth Smaller Companies Trust (ASL) 568.00p +0.89%Dechra Pharmaceuticals (DPH) 487.20p +0.87%FTSE 250 - FallersInvensys (ISYS) 214.60p -16.50%Aquarius Platinum Ltd. (AQP) 54.00p -9.55%Ferrexpo (FXPO) 211.50p -4.94%Afren (AFR) 105.00p -4.20%Man Group (EMG) 74.65p -4.11%Heritage Oil (HOIL) 124.70p -4.08%Bellway (BWY) 775.00p -4.02%Home Retail Group (HOME) 83.60p -3.91%Centamin (DI) (CEY) 66.50p -3.76%Petropavlovsk (POG) 465.70p -3.48%BC
More News
18 Dec 2023 07:18

GSK sees success in Jemperli endometrial cancer trial

(Sharecast News) - GSK released positive headline results from the planned analysis of its trial of Jemperli in endometrial cancer on Monday.

Read more
17 Dec 2023 15:16

PRESS: GSK looks for deals in China as rebuilds relationship

(Alliance News) - The Financial Times on Sunday reported that GSK PLC is looking for some new deals in China.

Read more
15 Dec 2023 17:08

European shares end fifth week higher on rate-cut optimism

Barclays sees first ECB rate cut in April

*

Read more
15 Dec 2023 16:51

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.

Read more
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more
12 Dec 2023 08:22

TOP NEWS: Japan accepts GSK's filing for respiratory disease vaccine

(Alliance News) - GSK PLC on Tuesday said Japan's Ministry of Health, Labour & Welfare has accepted its regulatory application for the extension of its respiratory syncytial virus vaccine, Arexvy, for adults aged 50-59.

Read more
12 Dec 2023 07:39

LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI

(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation.

Read more
12 Dec 2023 07:24

GSK seeks to extend RSV vaccine approval in Japan

(Sharecast News) - GSK announced on Tuesday that Japan's Ministry of Health, Labour and Welfare (MHLW) has accepted its regulatory application for the extension of the indication of its RSV vaccine to include adults aged 50- to 59 at an increased risk of contracting the disease.

Read more
11 Dec 2023 08:28

GSK drug gets EU marketing backing for form of endometrial cancer

(Alliance News) - GSK PLC on Monday said it won EU backing for its Jemperli drug in tandem with chemotherapy to treat a form of endometrial cancer.

Read more
11 Dec 2023 07:41

LONDON BRIEFING: GSK drug gets EU endorsement; Begbies backs outlook

(Alliance News) - London's FTSE 100 is called to open a touch lower on Monday, kicking off the week with some slight trepidation after Friday's hotter-than-expected US jobs report which offered the dollar some respite.

Read more
11 Dec 2023 07:23

GSK endometrial cancer treatment gets Europe authorisation

(Sharecast News) - GSK announced on Monday that the European Commission has granted marketing authorisation for 'Jemperli', or dostarlimab, in combination with chemotherapy for certain endometrial cancers.

Read more
7 Dec 2023 12:54

THG backer Kelso pushes for demerger to trim "inherent" valuation gap

(Alliance News) - THG PLC investor Kelso Group Holdings PLC on Thursday reiterated its call for a demerger, which the shareholder believes will help close the "disparity" between the e-commerce firm's share price and its true value.

Read more
5 Dec 2023 10:02

LONDON BROKER RATINGS: Goldman lifts Landsec and British Land

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
27 Nov 2023 09:00

GSK announces positive results from Blenrep phase 3 blood cancer trial

(Alliance News) - GSK PLC on Monday said a phase 3 trial of belantamab mafodotin as a multiple myeloma treatment has produced positive headline results.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.